Recent Analysts’ Ratings Changes for Elanco Animal Health (ELAN)

A number of research firms have changed their ratings and price targets for Elanco Animal Health (NASDAQ: ELAN):

  • 10/15/2018 – Elanco Animal Health is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $38.00 price target on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Cowen Inc. They set an “outperform” rating on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Credit Suisse Group AG. They set a “neutral” rating and a $36.00 price target on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Bank of America Corp. They set a “neutral” rating and a $34.00 price target on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Goldman Sachs Group Inc. They set a “neutral” rating and a $30.00 price target on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $35.00 price target on the stock.
  • 10/15/2018 – Elanco Animal Health is now covered by analysts at Citigroup Inc. They set a “buy” rating and a $37.00 price target on the stock.
  • 10/12/2018 – Elanco Animal Health is now covered by analysts at Craig Hallum. They set a “hold” rating on the stock.
  • 9/26/2018 – Elanco Animal Health is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $33.00 price target on the stock.
  • 9/19/2018 – Elanco Animal Health is now covered by analysts at Gabelli. They set a “buy” rating and a $32.00 price target on the stock.

Shares of ELAN stock opened at $31.88 on Tuesday. Elanco Animal Health has a 1 year low of $31.20 and a 1 year high of $37.61.

In other news, CEO Jeffrey N. Simmons acquired 22,000 shares of the company’s stock in a transaction dated Monday, September 24th. The shares were bought at an average price of $24.00 per share, with a total value of $528,000.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Lawrence Erik Kurzius acquired 10,000 shares of the company’s stock in a transaction dated Monday, September 24th. The stock was purchased at an average cost of $24.00 per share, for a total transaction of $240,000.00. The disclosure for this purchase can be found here. Insiders have acquired a total of 33,000 shares of company stock valued at $792,000 in the last quarter.

A hedge fund recently bought a new stake in Elanco Animal Health stock. First Manhattan Co. acquired a new position in Elanco Animal Health (NASDAQ:ELAN) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 10,000 shares of the company’s stock, valued at approximately $348,000.

There is no company description available for Elanco Animal Health Inc

Featured Article: Marijuana Stocks

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply